The U.S. Supreme Court on Wednesday extended until Friday at midnight an administrative stay in an ongoing lower-court fight over the FDA-approved use of the abortion pill mifepristone.
The Supreme Court is deciding whether women will face restrictions in getting a drug used in the most common method of abortion in the United States, while a lawsuit continues.
The U.S. Supreme Court was set on Tuesday to consider a bid by whistleblowers to revive lawsuits accusing pharmacy operators of pocketing millions of taxpayer dollars by knowingly overbilling government health insurance programs.
The first ever over-the-counter version of the opioid overdose reversal drug naloxone was approved by the FDA Wednesday, a move that could dramatically increase access to a life saving medication.
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.